Create account

Coverage dated August 7, 2022 to August 8, 2022

Only Lyme disease vaccine in development goes to Phase 3 trial

Headline from ABC 12 Flint, on the newest of 2 developments

Vaccine maker Pfizer says it has begun Phase 3 clinical trial of its vaccine candidate against Lyme disease with French vaccine company Valneva SE.

ABC 12 Flint's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Lyme disease vaccine: 1st potential shot in 20 years enters late-stage trial

    Headline from FOX 29 Philadelphia ·

  2. Newest

    Only Lyme disease vaccine in development goes to Phase 3 trial

    Headline from ABC 12 Flint ·

Read the reports

Reports & sources

43 articles, oldest first.

  1. Omaha World-Herald

    Major test of first possible Lyme vaccine in 20 years begins (opens Omaha World-Herald)

    Published

    Omaha World-Herald's feed description

    Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years. The shot developed by Pfizer and French

  2. WNYT Albany

    Long-awaited Lyme vaccine test begins (opens WNYT Albany)

    Published

    WNYT Albany's feed description

    Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the tick-borne menace.

  3. NBC News

    Pfizer just started a late-stage clinical trial of a Lyme disease vaccine (opens NBC News)

    Published

    NBC News's feed description

    If the trial succeeds, the vaccine could be the first human immunization for Lyme disease in the U.S. in two decades.

  4. FOX 29 Philadelphia

    Lyme disease vaccine: 1st potential shot in 20 years enters late-stage trial (opens FOX 29 Philadelphia)

    Published

    FOX 29 Philadelphia's feed description

    The only prior Lyme vaccine for people, made by another company, was pulled off the U.S. market in 2002.

  5. ABC 12 Flint

    Only Lyme disease vaccine in development goes to Phase 3 trial (opens ABC 12 Flint)

    Published

    ABC 12 Flint's feed description

    Vaccine maker Pfizer says it has begun Phase 3 clinical trial of its vaccine candidate against Lyme disease with French vaccine company Valneva SE.

  6. ZME Science

    Pfizer is trying to bring a Lyme disease vaccine back to market, 20 years after the last one was pulled (opens ZME Science)

    Published

    ZME Science's feed description

    It would greatly help our efforts to contain Lyme disease.

  7. FOX Business

    Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial (opens FOX Business)

    Published

    FOX Business's feed description

    On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.

  8. PhillyVoice

    The first Lyme disease vaccine in 20 years moves closer to reality (opens PhillyVoice)

    Published

    PhillyVoice's feed description

    The inoculation could prove particularly helpful in Pennsylvania, which records more cases of the tick-borne illness than any state

  9. NPR

    A vaccine for Lyme disease is in its final clinical trial (opens NPR)

    Published

    NPR's feed description

    There isn't currently a Lyme disease vaccine on the U.S. market. Researchers are hoping to change that.

  10. CBS News

    Pfizer, French firm starting testing of major Lyme disease vaccine (opens CBS News)

    Published

    CBS News's feed description

    It would be the first major vaccine of its type in 20 years. The companies are seeking thousands of volunteers in the U.S. and Europe as cases keep rising.

  11. FOX 5 New York

    Potential Lyme disease vaccine: Major test begins (opens FOX 5 New York)

    Published

    FOX 5 New York's feed description

    Researchers are seeking thousands of volunteers to test the first potential vaccine against Lyme disease in 20 years. The shot developed by Pfizer and French biotech Valneva aims to block Lyme spread while a tick is biting.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Only Lyme disease vaccine in development goes to Phase 3 trial | Since Then